Effect of prednisolone acetate eye drops on blood glucose profile in Indian population

Background: One of the common indications of topical steroids is to control postoperative inflammation. This study aims to evaluate changes in blood glucose concentrations in diabetic and nondiabetic patients treated with a postoperative regimen of 1% topical prednisolone acetate after cataract surg...

Full description

Saved in:
Bibliographic Details
Main Authors: Archana Bhat, Prajakta Paritekar, Y. Umesh
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2025-01-01
Series:Journal of Clinical Ophthalmology and Research
Subjects:
Online Access:https://journals.lww.com/10.4103/jcor.jcor_95_24
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832087201462091776
author Archana Bhat
Prajakta Paritekar
Y. Umesh
author_facet Archana Bhat
Prajakta Paritekar
Y. Umesh
author_sort Archana Bhat
collection DOAJ
description Background: One of the common indications of topical steroids is to control postoperative inflammation. This study aims to evaluate changes in blood glucose concentrations in diabetic and nondiabetic patients treated with a postoperative regimen of 1% topical prednisolone acetate after cataract surgery. Materials and Methods: Prospective, observational cohort study conducted in a tertiary eye care hospital in South India from August 2022 to May 2023. Nondiabetics (Group A) and diabetics with good glycemic control, i.e., glycated hemoglobin (HbA1c) <7% (Group B) undergoing routine uneventful cataract surgery by a single surgeon were included in the study. All patients were prescribed the same regimen of topical corticosteroids after cataract surgery for 2 weeks, i.e., topical prednisolone acetate 1%, 1 drop six times a day for 1 week followed by three times a day for 1 week. All patients underwent capillary fasting blood sugar (FBS) test at the following time points: before the start of surgery, 1-week postoperative, 1-month postoperative, and HbA1c at 3 months postoperative. Results: Forty nondiabetic patients (Group A) and 40 well-controlled diabetic patients (Group B) were included in the study. Group A showed a statistically significant increase when 1-week preoperative FBS level (105.9 ± 13.3) was compared with 1-week postoperative (114.42 ± 15.6) which returned to the pretreatment level (102.92 ± 8.9) on 1-month follow-up. In Group B, 1-week preoperative (126.05 ± 31.2) and 1-week postoperative FBS levels (126.37 ± 19.5) were comparable. Conclusion: Topical prednisolone acetate can be safely used as a short-term routine postcataract surgery regimen in nondiabetics and diabetics with good glycemic control, without a significant increase in blood sugar levels.
format Article
id doaj-art-14e28bbc587d4bb9ae0196f2aefcde73
institution Kabale University
issn 2320-3897
2320-3900
language English
publishDate 2025-01-01
publisher Wolters Kluwer Medknow Publications
record_format Article
series Journal of Clinical Ophthalmology and Research
spelling doaj-art-14e28bbc587d4bb9ae0196f2aefcde732025-02-06T06:38:52ZengWolters Kluwer Medknow PublicationsJournal of Clinical Ophthalmology and Research2320-38972320-39002025-01-01131576010.4103/jcor.jcor_95_24Effect of prednisolone acetate eye drops on blood glucose profile in Indian populationArchana BhatPrajakta ParitekarY. UmeshBackground: One of the common indications of topical steroids is to control postoperative inflammation. This study aims to evaluate changes in blood glucose concentrations in diabetic and nondiabetic patients treated with a postoperative regimen of 1% topical prednisolone acetate after cataract surgery. Materials and Methods: Prospective, observational cohort study conducted in a tertiary eye care hospital in South India from August 2022 to May 2023. Nondiabetics (Group A) and diabetics with good glycemic control, i.e., glycated hemoglobin (HbA1c) <7% (Group B) undergoing routine uneventful cataract surgery by a single surgeon were included in the study. All patients were prescribed the same regimen of topical corticosteroids after cataract surgery for 2 weeks, i.e., topical prednisolone acetate 1%, 1 drop six times a day for 1 week followed by three times a day for 1 week. All patients underwent capillary fasting blood sugar (FBS) test at the following time points: before the start of surgery, 1-week postoperative, 1-month postoperative, and HbA1c at 3 months postoperative. Results: Forty nondiabetic patients (Group A) and 40 well-controlled diabetic patients (Group B) were included in the study. Group A showed a statistically significant increase when 1-week preoperative FBS level (105.9 ± 13.3) was compared with 1-week postoperative (114.42 ± 15.6) which returned to the pretreatment level (102.92 ± 8.9) on 1-month follow-up. In Group B, 1-week preoperative (126.05 ± 31.2) and 1-week postoperative FBS levels (126.37 ± 19.5) were comparable. Conclusion: Topical prednisolone acetate can be safely used as a short-term routine postcataract surgery regimen in nondiabetics and diabetics with good glycemic control, without a significant increase in blood sugar levels.https://journals.lww.com/10.4103/jcor.jcor_95_24blood sugarcataract surgerytopical prednisolone acetate
spellingShingle Archana Bhat
Prajakta Paritekar
Y. Umesh
Effect of prednisolone acetate eye drops on blood glucose profile in Indian population
Journal of Clinical Ophthalmology and Research
blood sugar
cataract surgery
topical prednisolone acetate
title Effect of prednisolone acetate eye drops on blood glucose profile in Indian population
title_full Effect of prednisolone acetate eye drops on blood glucose profile in Indian population
title_fullStr Effect of prednisolone acetate eye drops on blood glucose profile in Indian population
title_full_unstemmed Effect of prednisolone acetate eye drops on blood glucose profile in Indian population
title_short Effect of prednisolone acetate eye drops on blood glucose profile in Indian population
title_sort effect of prednisolone acetate eye drops on blood glucose profile in indian population
topic blood sugar
cataract surgery
topical prednisolone acetate
url https://journals.lww.com/10.4103/jcor.jcor_95_24
work_keys_str_mv AT archanabhat effectofprednisoloneacetateeyedropsonbloodglucoseprofileinindianpopulation
AT prajaktaparitekar effectofprednisoloneacetateeyedropsonbloodglucoseprofileinindianpopulation
AT yumesh effectofprednisoloneacetateeyedropsonbloodglucoseprofileinindianpopulation